AR and posterior cortical atrophy: Despite the effort to inhibit the AR in advanced hormone-independent stages with apalutamide, darolutamide, or enzalutamide, some PCa cells are able to bypass these interventions through lineage plasticity [6] and AR mutations [7], leading to tumors that are more aggressive.